1-10 of 10
Xiaoqi Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate Cancer

Elia Farah, Zhuangzhuang Zhang, Sagar M. Utturkar, Jinpeng Liu, Timothy L. Ratliff, Xiaoqi Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (1): 193–205.
https://doi.org/10.1158/1535-7163.MCT-21-0581
Published: 07 January 2022
View article titled, Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate Cancer
Open the PDF for Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Potent Synergistic Effect on C-Myc–Driven Colorectal Cancers Using a Novel Indole-Substituted Quinoline with a Plk1 Inhibitor

Yanqi Xie, Wen Zhang, Lichao Guo, Liliia M. Kril, Kristin L. Begley, Vitaliy M. Sviripa, Xi Chen, Xifu Liu, Eun Y. Lee, Daheng He, Chi Wang, Tianyan Gao, Xiaoqi Liu, B. Mark Evers, David S. Watt, Chunming Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (10): 1893–1903.
https://doi.org/10.1158/1535-7163.MCT-20-1017
Published: 01 October 2021
View article titled, Potent Synergistic Effect on C-Myc–Driven Colorectal Cancers Using a Novel Indole-Substituted Quinoline with a Plk1 Inhibitor
Open the PDF for Potent Synergistic Effect on C-Myc–Driven Colorectal Cancers Using a Novel Indole-Substituted Quinoline with a Plk1 Inhibitor in another window
Includes: Supplementary data
Journal Articles

Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer

Yifan Kong, Yanquan Zhang, Fengyi Mao, Zhuangzhuang Zhang, Zhiguo Li, Ruixin Wang, Jinghui Liu, Xiaoqi Liu
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2020) 19 (12): 2490–2501.
https://doi.org/10.1158/1535-7163.MCT-19-0874
Published: 02 December 2020
View article titled, Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer
Open the PDF for Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer

Fengyi Mao, Jie Li, Qian Luo, Ruixin Wang, Yifan Kong, Colin Carlock, Zian Liu, Bennet D. Elzey, Xiaoqi Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (7): 1554–1565.
https://doi.org/10.1158/1535-7163.MCT-17-0945
Published: 01 July 2018
View article titled, Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer
Open the PDF for Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Targeting Polo-like Kinase 1 by a Novel Pyrrole-Imidazole Polyamide–Hoechst Conjugate Suppresses Tumor Growth In Vivo

Ke Liu, Lijing Fang, Haiyan Sun, Zhengyin Pan, Jianchao Zhang, Juntao Chen, Ximing Shao, Wei Wang, Yuanyan Tan, Zhihao Ding, Lijiao Ao, Chunlei Wu, Xiaoqi Liu, Huashun Li, Rui Wang, Wu Su, Hongchang Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (5): 988–1002.
https://doi.org/10.1158/1535-7163.MCT-17-0747
Published: 30 April 2018
View article titled, Targeting Polo-like Kinase 1 by a Novel Pyrrole-Imidazole Polyamide–Hoechst Conjugate Suppresses Tumor Growth <em>In Vivo</em>
Open the PDF for Targeting Polo-like Kinase 1 by a Novel Pyrrole-Imidazole Polyamide–Hoechst Conjugate Suppresses Tumor Growth <em>In Vivo</em> in another window
Includes: Multimedia, Supplementary data
Journal Articles

Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer

Jie Li, Ruixin Wang, Yifan Kong, Meaghan M. Broman, Colin Carlock, Long Chen, Zhiguo Li, Elia Farah, Timothy L. Ratliff, Xiaoqi Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (3): 469–479.
https://doi.org/10.1158/1535-7163.MCT-16-0361
Published: 02 March 2017
View article titled, Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer
Open the PDF for Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer

Long Chen, Jie Li, Elia Farah, Sukumar Sarkar, Nihal Ahmad, Sanjay Gupta, James Larner, Xiaoqi Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (9): 2107–2118.
https://doi.org/10.1158/1535-7163.MCT-16-0241
Published: 01 September 2016
View article titled, Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer
Open the PDF for Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics

Rosie Elizabeth Ann Gutteridge, Mary Ann Ndiaye, Xiaoqi Liu, Nihal Ahmad
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (7): 1427–1435.
https://doi.org/10.1158/1535-7163.MCT-15-0897
Published: 05 July 2016
View article titled, Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
Open the PDF for Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics in another window
Journal Articles

Abstract A06: Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness

Hyeon Jeong Lee, Shuhua Yue, Junjie Li, Seung-Young Lee, Tian Shao, Bing Song, Liang Cheng, Timothy A. Masterson, Xiaoqi Liu, Timothy L. Ratliff, Ji-Xin Cheng
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (7_Supplement): A06.
https://doi.org/10.1158/1538-8514.PI3K14-A06
Published: 06 July 2015
View article titled, Abstract A06: Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness
Journal Articles

Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer

Bing Song, X. Shawn Liu, Steven J. Rice, Shihuan Kuang, Bennett D. Elzey, Stephen F. Konieczny, Timothy L. Ratliff, Tony Hazbun, Elena G. Chiorean, Xiaoqi Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (1): 58–68.
https://doi.org/10.1158/1535-7163.MCT-12-0632
Published: 13 January 2013
View article titled, Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer
Open the PDF for Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer in another window
Includes: Supplementary data